Pilot Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization
Description:
Subjects will receive HBOT daily for 10 days in conjunction with standard growth factor
treatment regimens for stem cell mobilization. The role of HBOT in stem cell mobilization as
well as its role on oxidative stress will be evaluated.
Condition:
Multiple Myeloma
Treatment:
Hyperbaric Oxygen Therapy
Start Date:
February 2012
Sponsor:
University of Arkansas
For More Information:
https://clinicaltrials.gov/show/NCT01449539